Abstract
Gene–environment interactions are hypothesized to be major contributors to susceptibility to environmental carcinogens and interindividual variability in cancer risk. We present findings on associations between genetic susceptibility due to inherited polymorphisms of the Phase II detoxification enzyme sulfotransferase 1A1 (SULT1A1), breast cancer risk, and polycyclic aromatic hydrocarbon (PAH)-DNA adducts. A hospital based case-control study was conducted at the New York-Presbyterian Medical Center (NYPMC). The study utilized two control groups: one comprised of women with benign breast disease (BBD) and the other comprised of women visiting NYPMC for routine gynecologic checkups (healthy controls). Blood samples were collected from cases and controls; and breast tissue from pathology blocks was collected from cases (tumor and non-tumor tissue) and BBD controls (benign tissue). PAH-DNA adduct levels were measured by immunohistochemistry in breast tissue samples, and the SULT1A1 (Arg/His) polymorphism at codon 213 was determined by PCR RFLP analyses using DNA from white blood cells. Increasing number of His alleles was modestly associated with breast cancer case-control status, when cases were compared to healthy controls (p for trend = 0.08), when cases were compared to BBD controls (p for trend = 0.08) and when cases were compared to both control groups combined (p for trend = 0.07). Contrary to our hypothesis PAH-DNA adduct levels in breast tissue were not associated with SULT1A1 genotype. Our findings are consistent with a prior report that the Arg/His polymorphism in SULT1A1 is associated with breast cancer risk.
Similar content being viewed by others
References
ACS (American Cancer Society): Cancer Facts and Figures. American Cancer Society, 2002
El-Bayoumy K: Environmental carcinogens that may be involved in human breast cancer etiology. Chem Res Toxicol 5: 570-585, 1992
Perera FP, Estabrook A, Hewer A, Channing KM, Rundle A, Mooney LA, Whyatt R, Phillips DH: Carcinogen-DNA adducts in human breast tissue. Cancer Epidemiol Biomarkers Prev 4: 233-238, 1995
Li D, Wang M, Dhingra K, Hittelman W: Aromatic DNA adducts in adjacent tissues of breast cancer patients: clues to breast cancer etiology. Cancer Res 56: 287-293, 1996
Rundle A, Tang D, Hibshoosh H, Estabrook A, Schnabel F, Cao W, Grumet S, Della Rocca A, Perera F: The relationship between genetic damage from polycyclic aromatic hydrocarbons in breast tissue and breast cancer. Carcinogenesis 21: 1281-1289, 2000
Helzlsouer KJ, Selmin O, Huang HY, Strickland PT, Hoffman S, Alberg AJ, Watson M, Comstock GW, Bell D: Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Natl Cancer Inst 90: 512-518, 1998
Rundle A, Tang D, Zhou J, Cho S, Perera F: The association between glutathione-S-transferase-M1 genotype and polycyclic aromatic hydrocarbon (PAH)-DNA adducts in breast tissue. Cancer Epidemiol Biomarkers Prev 9: 1079-1085, 2000
Zheng W, Xie D, Cerhan JR, Sellers TA, Wen W, Folsom AR: Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 10: 89-94, 2001
Weinshilboum RM, Otterness DM, Aksoy IA, Wood TC, Her C, Raftogianis RB: Sulfation and sulfotransferases 1: sulfotransferase molecular biology: cDNAs and genes. FASEB J 11: 3-14, 1997
Falany CN: Enzymology of human cytosolic sulfotransferases. FASEB J 11: 206-216, 1997
Glatt H: Bioactivation of mutagens via sulfation. FASEB J 11: 314-321, 1997
Williams JA, Stone EM, Fakis G, Johnson N, Cordell JA, Meinl W, Glatt H, Sim E, Phillips DH: N-Acetyltransferases, sulfotransferases and heterocyclic amine activation in the breast. Pharmacogenetics 11: 373-388, 2001
Raftogianis RB, Wood TC, Otterness DM, Van Loon JA, Weinshilboum RM: Phenol sulfotransferase pharmacogenetics in humans: association of common SULT1A1 alleles with TS PST phenotype. Biochem Biophys Res Commun 239: 298-304, 1997
Raftogianis RB, Wood TC, Weinshilboum RM: Human phenol sulfotransferases SULT1A2 and SULT1A1: genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations. Biochem Pharmacol 58: 605-616, 1999
International Agency for Research on Cancer: Polynuclear aromatic compounds. Part 1. Chemical, environmental, and experimental data. IARCMonographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Vol 32, International Agency for Research on Cancer Lyon, France, 1983, pp. 1-453
US EPA: Aerometric Information Retrieval System (AIRS), Data for 1985-1990. Dr. R. Faoro. Environmental Protection Agency Research Triangle Park, NC, 1990.
Moore CJ, Tricomi WA, Gould MN: Interspecies comparison of polycyclic aromatic hydrocarbon metabolism in human and rat mammary epithelial cells. Cancer Res 46: 4946-4952, 1986
Calaf G, Russo J: Transformation of human breast epithelial cells by chemical carcinogens. Carcinogenesis 14: 483-492, 1993
Eldridge SR, Gould MN, Butterworth BE: Genotoxicity of environmental agents in human mammary epithelial cells. Cancer Res 52: 5617-5621, 1992
Mane S, Purnell D, Hsu IC: Genotoxic effects of five polycyclic aromatic hydrocarbons in human and rat mammary epithelial cells. Environ Mol Mutagen 15: 78-82, 1990
Miller JA: Sulfonation in chemical carcinogenesis-history and present status. Chem Biol Interact 92: 329-341, 1994
Surh YJ, Miller JA: Roles of electrophilic sulfuric acid ester metabolites in mutagenesis and carcinogenesis by some polynuclear aromatic hydrocarbons. Chem Biol Interact 92: 351-362, 1994
Miller EC, Miller JA: Mechanisms of chemical carcinogenesis. Cancer 47: 1055-1064, 1981
Rundle A, Tang D, Hibshoosh H, Schnabel F, Kelly A, Levine R, Zhou Z, Link B, Perera F: Molecular epidemiologic studies of polycyclic aromatic hydrocarbon-DNA adducts and breast cancer. Environ Mol Mutagen 39: 201-207, 2002
Zhang YJ, Weksler BB, Wang L, Schwartz J, Santella RM: Immunohistochemical detection of polycyclic aromatic hydrocarbon-DNA damage in human blood vessels of smokers and non-smokers. Atherosclerosis 140: 325-331, 1998
Flanders WD, DerSimonian R, Freedman DS: Interpretation of linear regression models that include transformations or interaction terms. Ann Epidemiol 2: 735-744, 1992
Glatt H: Sulfotransferases in the bioactivation of xenobiotics. Chem-Biol Interact 129: 141-170, 2000
Williams JA, Martin FL, Muir GH, Hewer A, Grover PL, Phillips DH.: Metabolic activation or carcinogens and expression of various cytochromes P450 in human prostate tissue. Carcinogenesis 21: 1683-1689, 2000
Falany JL, Falany CN: Expression of cytosolic sulfotransferases in normal mammary epithelial cells and breast cancer cell lines. Cancer Res 56: 1551-1555, 1996
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tang, D., Rundle, A., Mooney, L. et al. Sulfotransferase 1A1 (SULT1A1) Polymorphism, PAH-DNA Adduct Levels in Breast Tissue and Breast Cancer Risk in a Case-Control Study. Breast Cancer Res Treat 78, 217–222 (2003). https://doi.org/10.1023/A:1022968303118
Issue Date:
DOI: https://doi.org/10.1023/A:1022968303118